Wellcome Genome Campus, Hinxton, Cambridge
Deadlines: Early bird discount 27 Feb | Bursary 13 Mar
We are pleased to announce the third in our series of meetings on mitochondrial disorders and the search for novel effective therapies. Mitochondrial diseases are the largest group of inherited metabolic disorders, and the past decade has seen major advances in our understanding of the molecular mechanisms involved.
The year’s meeting aims to bridge the gap between our current understanding of the mechanisms and processes that go awry in mitochondrial disease and the novel approaches being developed to treat them. We will also include sessions on clinical trial design and cohorts that are trial ready. In addition, there will be a late-breaking session focusing on new clinical intervention studies.
This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine.
For more details click here